JACOBS LEVY EQUITY MANAGEMENT, INC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 74 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$253,950
-86.8%
37,903
-87.2%
0.00%
-91.7%
Q1 2023$1,922,214
-24.5%
295,271
-1.1%
0.01%
-29.4%
Q4 2022$2,547,195
+7.0%
298,616
-33.8%
0.02%
-10.5%
Q3 2022$2,380,000450,8340.02%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$12,721,0003.35%
Orbimed Advisors 8,740,887$58,214,0000.75%
Nantahala Capital Management 1,006,462$6,703,0000.24%
EcoR1 Capital, LLC 1,060,010$7,060,0000.22%
Prosight Management, LP 53,815$358,0000.21%
RA Capital Management 1,742,186$11,603,0000.20%
Endurant Capital Management LP 84,295$561,0000.14%
HighVista Strategies LLC 22,434$149,0000.12%
XTX Topco Ltd 18,816$125,0000.07%
WASATCH ADVISORS LP 1,773,690$11,813,0000.05%
View complete list of SILVERBACK THERAPEUTICS INC shareholders